» Articles » PMID: 18018481

Low Grade Ganglioglioma Rapidly Progressing to a WHO Grade IV Tumor Showing Malignant Transformation in Both Astroglial and Neuronal Cell Components

Overview
Journal Neuropathology
Specialties Neurology
Pathology
Date 2007 Nov 21
PMID 18018481
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Gangliogliomas are rare CNS neoplasms mostly occuring in young adults and are usually assigned to WHO grade I. The few cases of WHO grade IV gangliogliomas were either primarily malignant glio-neuronal tumors or underwent malignant progression from other WHO grades after radiotherapy. Herein, we present the case of a now 47-year-old female patient presenting with a benign ganglioglioma and showing a tumor recurrence 2 years later with an anaplastic ganglioglioma, assigned to WHO grade IV, with malignant transformation in both glial and neuronal components. The presented case is the first reported low-grade ganglioglioma rapidly progressing to a WHO grade IV glio-neuronal tumor not being associated with radiotherapy and showing malignant transformation in both astroglial and neuronal tumor cell components.

Citing Articles

Adult cerebral high-grade glioneuronal tumor with perivascular or pseudopapillary growth co-existing with low-grade tumor: a case report.

Shintaku M, Ohta M, Chihara H, Yokoo H, Noda Y, Tsuta K Int J Clin Exp Pathol. 2023; 16(10):294-302.

PMID: 37970335 PMC: 10641370.


Practical aspects regarding the histopathological grading and anaplastic transformation of gangliogliomas - a literature review.

Lisievici A, Lisievici M, Pasov D, Georgescu T, Munteanu O, Grigoriu C Rom J Morphol Embryol. 2022; 62(2):385-393.

PMID: 35024726 PMC: 8848234. DOI: 10.47162/RJME.62.2.04.


Ganglioside Composition Distinguishes Anaplastic Ganglioglioma Tumor Tissue from Peritumoral Brain Tissue: Complementary Mass Spectrometry and Thin-Layer Chromatography Evidence.

Fabris D, Karmelic I, Muharemovic H, Sajko T, Jurilj M, Potocki S Int J Mol Sci. 2021; 22(16).

PMID: 34445547 PMC: 8396361. DOI: 10.3390/ijms22168844.


Prolonged Response Induced by Single Agent Vemurafenib in a Spinal Ganglioglioma: A Case Report and Review of the Literature.

Garnier L, Ducray F, Verlut C, Mihai M, Cattin F, Petit A Front Oncol. 2019; 9:177.

PMID: 30984614 PMC: 6448025. DOI: 10.3389/fonc.2019.00177.


Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database.

Terrier L, Bauchet L, Rigau V, Amelot A, Zouaoui S, Filipiak I Neuro Oncol. 2017; 19(5):678-688.

PMID: 28453747 PMC: 5464461. DOI: 10.1093/neuonc/now186.